Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

5.120 +0.020 (+0.39%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	976,916
Open	5.120
Bid (Size)	5.000 (200)
Ask (Size)	5.300 (500)
Prev. Close	5.100
Today's Range	5.015 - 5.280
52wk Range	3.760 - 15.47
Shares Outstanding	93,100,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Cash-Burning Stocks We Keep Off Our Radar

February 05, 2026

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

Via StockStory

1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm

February 02, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Performance

YTD	-16.6%	-16.6%
1 Month	-21.5%	-21.5%
3 Month	-19.1%	-19.1%
6 Month	-16.1%	-16.1%
1 Year	-60.4%	-60.4%

More News

Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

January 27, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm

January 21, 2026

Via StockStory

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance

January 12, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

January 05, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

3 Stocks Under $10 We Think Twice About

January 04, 2026

Via StockStory

3 Unprofitable Stocks That Fall Short

January 01, 2026

Via StockStory

Myriad Genetics (MYGN) Stock Trades Up, Here Is Why

December 22, 2025

Via StockStory

Why Myriad Genetics (MYGN) Stock Is Up Today

December 09, 2025

Via StockStory

Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium

December 09, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?

December 08, 2025

Via StockStory

1 Healthcare Stock with Promising Prospects and 2 We Question

December 02, 2025

Via StockStory

Why Myriad Genetics (MYGN) Stock Is Trading Lower Today

December 01, 2025

Via StockStory

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

November 25, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know

November 24, 2025

Via StockStory

Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

November 21, 2025

Via StockStory

Why Myriad Genetics (MYGN) Stock Is Up Today

November 19, 2025

Via StockStory

Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment

November 18, 2025

Via StockStory

1 High-Flying Stock with Solid Fundamentals and 2 We Question

November 13, 2025

Via StockStory

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

November 11, 2025

Via StockStory

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

November 11, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

November 10, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

The Top 5 Analyst Questions From Myriad Genetics’s Q3 Earnings Call

November 10, 2025

Via StockStory

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference

November 06, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?

Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.

What exchange does Myriad Genetics, Inc. - Common Stock trade on?

Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?

The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market

What is the current price of Myriad Genetics, Inc. - Common Stock?

The current price of Myriad Genetics, Inc. - Common Stock is 5.120

When was Myriad Genetics, Inc. - Common Stock last traded?

The last trade of Myriad Genetics, Inc. - Common Stock was at 02/06/26 04:00 PM ET

What is the market capitalization of Myriad Genetics, Inc. - Common Stock?

The market capitalization of Myriad Genetics, Inc. - Common Stock is 476.67M

How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?

Myriad Genetics, Inc. - Common Stock has 477M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.